Lakefront Biotherapeutics | GLPG - Umsatzerlöse





Der Umsatz Veränderung Datum
argenx SE USD 1.36B 240M 2026-06
AstraZeneca USD 15.38B 90M 2026-06
Biogen USD 2.25B 30M 2026-03
Genmab DKK 1.06B 36M 2025-12
Gilead Sciences USD 7B 930M 2026-03
GlaxoSmithKline GBP 7.63B 991M 2026-03
GRIFOLS EUR 1.87B 170M 2026-06
Hikma Pharmaceutical USD 1.69B 863M 2025-12
Incyte USD 1.67B 400M 2026-06
Merck EUR 5.13B 120M 2026-03
Neurocrine Biosciences USD 811M 5.5M 2026-03
Novartis USD 14.41B 1.3B 2026-06
Roche Holding CHF 30.36B 14.71B 2026-06
Sanofi EUR 11.24B 60M 2026-03
UCB EUR 4.25B 764M 2025-12
Vertex Pharmaceuticals USD 2.99B 200M 2026-03